...rade; POLYSORB™ Soft Tissue Anchor 2 mm is a...ue to bone using sutures. The resorbable repair de..., and is used to reattach damaged soft tissue. The..., derived from glycolide and lactide colored with ...
This type of anchor is generally used when anchor size may be an issue. This 2.9mm anchor is packaged sterile and comes pre-loaded with sutures (1-0 or 2-0) and needles. Although pre-drilling is not
...nerally utilized when a surgeon would like to impa... seat the anchor below the 10-12 placement of the ... same as what comes with the Collared design, the ... to easier gauge anchor depth during insertion. Th...
...rade; Ogden™ Non-Sterile Anchor is a nonabso... using sutures. The device is implanted into a pre...aged soft tissue. The anchors are manufactured fro...M (F136-92). The anchors are coated with Titanium ...
Medicine Products:(Date:5/16/2008)... the aftermath of central China,s,earthquake, up t...es, and,over 150,000 were injured. An estimated 10... who have lost their homes. With great sorrow for,...ter Ching Hai donated an,additional US$30,000, for...reme Master Ching Hai International Association me...
(Date:5/16/2008)NEW YORK, May 16 /PRNewswire/ -- There,s more to a healthy mouth than,flashing a set of pearly whites. Here,s the scoop on America,s oral care,habits - and what it means for our overall health.,
(Date:5/16/2008)...SNewswire/ -- This release is,being sent in a soci...h the,National Cancer Institute, part of the NIH.,...rican Society of Clinical,Oncology meeting in Chic...e,in about 25 percent of patients with colon cance... colorectal cancers will be staged., * This new s...
(Date:5/16/2008)...can Society of Clinical Oncology meeting in Chicag...in about 25 percent of patients with colon cancer ...olorectal cancers will be staged. , This new s...opulation-based statistic registries from 1992 to ...t outcomes of patients with positive nodes (Stage ...
Breaking Medicine News(10 mins):Health News:Supreme Master Ching Hai International Association Delivering US$160,000 in Aid to Earthquake Survivors in China 2Health News:New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer 2...g investigated to find out how effectively it can ...g menopause. If successful, it might turn out to b...eplacement therapy instituted. It has been a prob...ecommend for patients who are not willing for horm...
...s had reported that men who report feeling nervous...ide than their counterparts who perceive themselve...ed // in the current issue of Journal of Epidemiol... are based on results from the Swedish Survey of L...
...hns Hopkins University School of Medicine had said...England Journal of Medicine that the disease calle... than people thought possible, to cause an outbre...nce of the recent outbreak in Arizona, US, as the ...
...ected leptospirosis and dengue in the densely popu... Mumbai over the pat three days has raised panic a...C) has been kept on high alert and has been forced...he area. The three suspected lepto victims died of...
Other Medicine News:Health News:Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts 2(Date:5/15/2008)...Newswire/ -- Ergonex Pharma today,announced that t...) has,granted orphan drug designation to Terguride...ion (PAH). Terguride is currently being evaluated ...The FDA,s grant of orphan drug designation to Terg...opment program by offering regulatory,clinical de...
(Date:5/15/2008)...wswire/ -- Tigris Pharmaceuticals,Inc. announced ...Development Agreement (CRADA) with the National Ca...d preclinical development of AFP-464, an,aminoflav...onverted to,metabolites which bind covalently to D...his is part of a four-year CRADA encompassing mult...
(Date:5/15/2008)...n Antiplatelet Therapy that, Combined, with Aspiri...avix/Iscover and Aspirin, According to a New R...y 15 /- Decision Resources, one of th...pharmaceutical and,healthcare issues, finds that D...nt in patient compared to Sanofi-Aventis/Bristol M...
(Date:5/15/2008)...A Trial data reports in third quarter ...RNewswire-FirstCall/ -- VIA Pharmaceuticals,Inc. ...on the development of,compounds for the treatment ... has completed patient enrollment in its acute cor...f three Phase 2 trials investigating VIA-2291,the...
Breaking Medicine Technology:Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 1090 1New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 1090 2New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 1090 3New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 1090 4New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 1090 5New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 1090 6New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 1090 7Insmed Receives FDA Orphan Drug Designation for IPLEX 28TM 29 in the Treatment of Myotonic Muscular Dystrophy 1085 1Insmed Receives FDA Orphan Drug Designation for IPLEX 28TM 29 in the Treatment of Myotonic Muscular Dystrophy 1085 2Insmed Receives FDA Orphan Drug Designation for IPLEX 28TM 29 in the Treatment of Myotonic Muscular Dystrophy 1085 3Creative work has health advantages Population Research Center study shows 8445 1Creative work has health advantages Population Research Center study shows 8445 2Study links success of invasive Argentine ants to diet shifts 1637 1Study links success of invasive Argentine ants to diet shifts 1637 2Study links success of invasive Argentine ants to diet shifts 1637 3...7,/PRNewswire-FirstCall/ --Eurand to present data ...ual,Meeting. ...tic insufficiency (EPI) is a,deficiency of digesti...reas that can result from a number , , of di...titis, and , , pancreatic cancer , , , --...
...n Hematology -, CHESHIRE, Conn., June 11, 2007 /PR...c. today announced results from three analyses,of ...b) for the,treatment of paroxysmal nocturnal hemog...ematology, organized by The European,Hematology As...luded: , "The Terminal Complement Inhibitor Eculiz...
Other Medicine Technology:Eurand to Present Zentase Phase III Data 2Eurand to Present Zentase Phase III Data 3Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients 2Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients 3Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients 4Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients 5Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients 6Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients 7